Remifentanil use in intensive care units: Current evidence and future perspectives
Abstract Pain management in intensive care units (ICUs) is crucial for improving patient outcomes. Remifentanil, an ultra‐short‐acting opioid, is metabolized independently of renal and hepatic function, making it an attractive analgesic. This article discusses the pharmacological effects of remifent...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2025-01-01
|
| シリーズ: | Acute Medicine & Surgery |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1002/ams2.70087 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|